Thread Is RSV worth having in over 80 years old!
The short version: the evidence block is empty, so there is no basis to answer this question.
The retrieved evidence contains no studies, no trials, no safety data, and no efficacy data for RSV vaccination in adults aged 80 or older. Without a single record to examine, I cannot tell you whether the vaccine reduces hospitalization, whether it causes harm, or whether it is worth taking. The gap itself matters. A manufacturer-funded trial with a surrogate endpoint would be weak evidence. No evidence at all is worse.
My call: there is no evidence to support or oppose the hypothesis. Confidence: not clear. The absence of retrieved evidence does not mean the vaccine is unsafe or ineffective. It means the question has not been answered by the material provided. That is the honest answer.
This page answers the follow-up:
Question explored with the scientific record
How does RSV risk reduction compare with no vaccine or alternative prevention?
The short version: the evidence block is empty, so there is no basis to compare RSV vaccination against nothing or any alternative in adults 80 and older.
The retrieved evidence contains no studies, no trials, no safety data, and no efficacy data for this age group. I cannot tell you whether the vaccine reduces hospitalization, whether it prevents death, or whether it harms. The gap itself is the finding. A manufacturer-funded trial with a surrogate endpoint would be weak evidence. No evidence at all is worse.
The most informative comparison, vaccinated versus truly unvaccinated over time, was never run in the material provided. Passive safety surveillance, if it existed here, would detect almost nothing by design. Absence of evidence is not evidence of safety.
My call: the hypothesis is unanswerable from the retrieved evidence. Confidence: not clear.